72 related articles for article (PubMed ID: 15752772)
1. Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection.
Shin-Ya M; Hirai H; Satoh E; Kishida T; Asada H; Aoki F; Tsukamoto M; Imanishi J; Mazda O
Biochem Biophys Res Commun; 2005 Apr; 329(3):1139-46. PubMed ID: 15752772
[TBL] [Abstract][Full Text] [Related]
2. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
3. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
5. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
6. Intracellular murine IFN-gamma mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors.
Will A; Hemmann U; Horn F; Röllinghoff M; Gessner A
J Immunol; 1996 Nov; 157(10):4576-83. PubMed ID: 8906836
[TBL] [Abstract][Full Text] [Related]
7. Phospholipid scramblase 1 potentiates the antiviral activity of interferon.
Dong B; Zhou Q; Zhao J; Zhou A; Harty RN; Bose S; Banerjee A; Slee R; Guenther J; Williams BR; Wiedmer T; Sims PJ; Silverman RH
J Virol; 2004 Sep; 78(17):8983-93. PubMed ID: 15308695
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN-alpha.
Grumbach IM; Fish EN; Uddin S; Majchrzak B; Colamonici OR; Figulla HR; Heim A; Platanias LC
J Interferon Cytokine Res; 1999 Jul; 19(7):797-801. PubMed ID: 10454351
[TBL] [Abstract][Full Text] [Related]
9. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.
Takaoka A; Hayakawa S; Yanai H; Stoiber D; Negishi H; Kikuchi H; Sasaki S; Imai K; Shibue T; Honda K; Taniguchi T
Nature; 2003 Jul; 424(6948):516-23. PubMed ID: 12872134
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
[TBL] [Abstract][Full Text] [Related]
11. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.
Yokota S; Yokosawa N; Okabayashi T; Suzutani T; Miura S; Jimbow K; Fujii N
J Virol; 2004 Jun; 78(12):6282-6. PubMed ID: 15163721
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
13. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.
Ramana CV; Kumar A; Enelow R
Biochem Biophys Res Commun; 2005 Feb; 327(3):727-33. PubMed ID: 15649407
[TBL] [Abstract][Full Text] [Related]
14. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
15. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
Improta T; Pine R
Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
[TBL] [Abstract][Full Text] [Related]
17. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
18. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
19. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
